| 查看: 880 | 回复: 0 | |||
852dd木虫 (正式写手)
|
[交流]
Rice University 博士后,博士招聘
|
|
Postdocs, graduate student, visiting student positions are available in the Chemical Biology Group of Dr. Han Xiao at Rice University (https://xiao.rice.edu). The focus of our research is the development of innovative chemical tools allowing us to understand complex biology system as well as develop novel therapeutic strategies. More information on the research program can be found at: https://xiao.rice.edu We are currently accepting applications for highly self-motivated postdocs, graduate student, visiting students with one of the following expertise: 1. Targeted Therapy: We are looking for scholars with a strong background in targeted therapy. Experience in antibody therapy, bispecific antibody therapy, animal work, and/or other immunotherapy is a plus. 2. Metabolic Engineering: We are looking for scholars with experiences in metabolic engineering to join this project. Candidates with experiences in genome editing, protein engineering, and/or cell engineering are preferred. 3. Photoactivatable Dyes: We are looking for scholars with a strong background in dye development, cell imaging, or photodynamic therapy. Experience in theoretical study is a plus. Please send your CV with publication list, and contact information for three references, to han.xiao@rice.edu. In addition, please indicate in the email your research interest, how it fits into the research program, and your expected career path. Rice University is a leading research university in the vibrant urban setting of Houston, TX, the fourth largest city in the U.S. Rice is a small, private university with exceptional strengths in natural science, engineering and biomedicine. Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. |
» 猜你喜欢
估计是周四
已经有3人回复
基金啊基金
已经有3人回复
科研孤儿太难了
已经有15人回复
让我中一个面上吧!
已经有10人回复
言之凿凿,明天官网会通知放榜?
已经有17人回复
时间戳又变了
已经有17人回复
今天系统多次维护,明天很可能放榜!
已经有11人回复
时间戳变了,能看出什么问题?
已经有23人回复
只有每年这种时候来逛逛小木虫
已经有22人回复
放榜前的不淡定
已经有12人回复









回复此楼
40